Elena Gonzalez-Rey Selected Research

Immune System Diseases (Immune Disorders)

9/2015	Lulling immunity, pain, and stress to sleep with cortistatin.
8/2010	Neuropeptides: keeping the balance between pathogen immunity and immune tolerance.
3/2009	Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses.
5/2008	Emergence of cortistatin as a new immunomodulatory factor with therapeutic potential in immune disorders.
1/2008	Vasoactive intestinal peptide inhibits cyclooxygenase-2 expression in activated macrophages, microglia, and dendritic cells.
11/2007	Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy.
9/2007	Anti-inflammatory neuropeptide receptors: new therapeutic targets for immune disorders?
9/2007	Tuning immune tolerance with vasoactive intestinal peptide: a new therapeutic approach for immune disorders.
6/2007	Vasoactive intestinal peptide and regulatory T-cell induction: a new mechanism and therapeutic potential for immune homeostasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elena Gonzalez-Rey Research Topics

Disease

18	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 11/2005
17	Inflammation (Inflammations) 01/2018 - 09/2004
13	Rheumatoid Arthritis 01/2017 - 09/2005
11	Experimental Arthritis 01/2015 - 03/2006
9	Immune System Diseases (Immune Disorders) 09/2015 - 06/2007
8	Colitis 01/2022 - 03/2006
7	Arthritis (Polyarthritis) 01/2017 - 01/2007
7	Multiple Sclerosis 01/2017 - 02/2006
7	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 03/2014 - 09/2005
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 03/2006
5	Sepsis (Septicemia) 09/2015 - 09/2006
5	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2009 - 05/2006
5	Crohn Disease (Crohn's Disease) 03/2009 - 03/2006
4	Parkinson Disease (Parkinson's Disease) 01/2013 - 10/2005
3	Pain (Aches) 06/2021 - 05/2013
3	Demyelinating Diseases (Demyelinating Disease) 03/2014 - 05/2013
3	Septic Shock (Toxic Shock Syndrome) 01/2007 - 03/2006
3	Leukemia 12/2006 - 05/2006
3	Diarrhea 12/2006 - 03/2006
2	Hyperalgesia 06/2021 - 05/2013
2	Cardiomegaly (Heart Hypertrophy) 01/2018 - 01/2017
2	Myocarditis (Carditis) 01/2018 - 01/2017
2	Atherosclerotic Plaque (Atheroma) 01/2018 - 01/2017
2	Atherosclerosis 01/2018 - 01/2017
2	Leishmaniasis 12/2013 - 01/2011
2	Weight Loss (Weight Reduction) 08/2013 - 12/2006
2	Alzheimer Disease (Alzheimer's Disease) 01/2013 - 08/2008
2	Infections 05/2009 - 06/2008
2	Hypersensitivity (Allergy) 07/2006 - 12/2005
2	Endotoxemia 06/2006 - 03/2006
2	Body Weight (Weight, Body) 05/2006 - 03/2006
1	Neuralgia (Stump Neuralgia) 06/2021
1	Peripheral Nerve Injuries 06/2021
1	Diabetic Neuropathies (Diabetic Neuropathy) 06/2021
1	Neointima 01/2018
1	Vascular Calcification 01/2017
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2017
1	Communicable Diseases (Infectious Diseases) 05/2014
1	Chronic Progressive Multiple Sclerosis 03/2014
1	Relapsing-Remitting Multiple Sclerosis 09/2013
1	Chronic Pain 05/2013
1	Osteoarthritis 05/2013
1	Neuroinflammatory Diseases 01/2013
1	Dementia (Dementias) 01/2013
1	Trypanosomiasis 01/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2010
1	Granuloma 08/2010
1	Sarcoidosis (Schaumann Disease) 08/2010
1	Disease Progression 08/2010

Drug/Important Bio-Agent (IBA)

24	NeuropeptidesIBA 06/2021 - 09/2005
20	Therapeutic UsesIBA 01/2018 - 03/2006
17	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2018 - 09/2005
12	cortistatinIBA 06/2021 - 03/2006
8	CytokinesIBA 01/2017 - 12/2005
7	Peptides (Polypeptides)IBA 06/2021 - 03/2006
6	AntigensIBA 05/2013 - 03/2006
5	Sulfonic AcidsIBA 01/2017 - 05/2006
4	Pharmaceutical PreparationsIBA 01/2018 - 07/2006
3	AdrenomedullinIBA 03/2014 - 06/2006
3	UrocortinsIBA 12/2013 - 06/2006
3	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 05/2013 - 05/2007
3	GhrelinIBA 05/2013 - 05/2006
2	Analgesics (Analgesic Drugs)IBA 06/2021 - 05/2013
2	ApolipoproteinsIBA 01/2018 - 01/2017
2	sym-trinitrobenzeneIBA 01/2017 - 01/2014
2	Collagen Type II (Type II Collagen)IBA 01/2017 - 01/2015
2	Dextran SulfateIBA 01/2017 - 01/2014
2	Interleukin-10 (Interleukin 10)IBA 08/2013 - 02/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2013 - 08/2010
2	Ghrelin ReceptorsIBA 05/2013 - 05/2007
2	Proteins (Proteins, Gene)FDA Link 10/2010 - 10/2007
2	(N- Ac- His(1)- Nle(17)- Arg(20,21)- Ala(26))- vasoactive intestinal peptideIBA 11/2007 - 12/2006
2	cortistatin AIBA 05/2007 - 03/2006
2	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 01/2007 - 09/2004
2	EndotoxinsIBA 06/2006 - 03/2006
2	Immunomodulating AgentsIBA 06/2006 - 03/2006
1	AP 1903 reagentIBA 01/2022
1	CholesterolIBA 01/2018
1	AutoantibodiesIBA 01/2017
1	Lenalidomide (CC 5013)FDA Link 01/2017
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2017
1	pomalidomideIBA 01/2017
1	LipidsIBA 01/2017
1	Apolipoproteins E (ApoE)IBA 01/2017
1	Inflammation MediatorsIBA 02/2014
1	Dextrans (Dextran)FDA Link 08/2013
1	SodiumIBA 08/2013
1	AcidsIBA 08/2013
1	GTP-Binding Proteins (G-Protein)IBA 05/2013
1	Calcitonin Gene-Related PeptideIBA 05/2013
1	SynucleinsIBA 01/2013
1	EnzymesIBA 01/2011
1	alpha-SynucleinIBA 10/2010

Therapy/Procedure

13	Therapeutics 06/2021 - 11/2005
4	Ligation 01/2018 - 03/2006
4	Bone Marrow Transplantation (Transplantation, Bone Marrow) 10/2009 - 05/2006
3	Punctures 08/2013 - 03/2006
2	Transplantation 09/2007 - 06/2007
1	Intraperitoneal Injections 01/2018
1	Oral Administration 01/2014